Sunil Healthcare Limited (SUNLOC) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE671C01016
Key metrics
- Market Cap
- ₹81 Cr
- P/E Ratio
- 22.76
- EPS
- 3.47
- Book Value
- 67.87
- P/B Ratio
- 1.18
- ROE
- 5.76%
- ROCE
- 5.05%
- Debt / Equity
- 0.8
- Net Margin
- 4.57%
- Revenue Growth
- 5.15%
- Profit Growth
- 382.79%
- Dividend Yield
- —
- 52W High
- ₹88.70
- 52W Low
- ₹56.35
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Sunil Healthcare Limited
Sunil Healthcare Limited engages in the manufacture and sale of empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India and internationally. Its products include EHG, BSE/TSE free, pearl, liquid fill, preservative free, stick free, flavored, SLS free, natural color, non-AZO, gelatin, HPMC/vegetable, and pullulan capsules. The company also provides ayurvedic products, such as haldi, ginger, vasaka, trifala, guduchi, salaki, punarvana, shatavari, hadjod, hingwastak, mulethi, arjuna, ashwagandha, and guggul extracts. The company offers its products under the SUNLOC brand name. Sunil Healthcare Limited was incorporated in 1973 and is based in New Delhi, India.
- Headquarters
- New Delhi, India
- Promoter Holding
- 88.18%
The full Sunil Healthcare Limited analysis
Create a free account to open the complete SUNLOC deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.